PubRank
Search
About
Rita Mehta
Author PubWeight™ 17.67
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy.
Proc Natl Acad Sci U S A
2007
3.27
2
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.
Breast Cancer Res
2005
2.68
3
Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy.
J Biomed Opt
2007
2.01
4
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.
Proc Natl Acad Sci U S A
2011
1.62
5
Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.
MAGMA
2006
1.40
6
Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.
Cancer Res
2012
1.28
7
NON-INVASIVE MEASUREMENT OF DEEP TISSUE TEMPERATURE CHANGES CAUSED BY APOPTOSIS DURING BREAST CANCER NEOADJUVANT CHEMOTHERAPY: A CASE STUDY.
J Innov Opt Health Sci
2011
0.92
8
Detection of choline signal in human breast lesions with chemical-shift imaging.
J Magn Reson Imaging
2008
0.90
9
Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer.
Technol Cancer Res Treat
2005
0.89
10
HER2 and response to paclitaxel in node-positive breast cancer.
N Engl J Med
2008
0.84
11
A prospective blinded study of the predictive value of an extreme drug resistance assay in patients receiving CPT-11 for recurrent glioma.
J Neurooncol
2004
0.82
12
Factors associated with success of the extreme drug resistance assay in primary breast cancer specimens.
Breast Cancer Res Treat
2002
0.79
13
Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy.
Am Surg
2014
0.75